GlassScriptPhysician profile
Laura B Haskins
NPI 1578775359
$1,713.31
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $750 · 2020: $568 · 2021: $176 · 2022: $94.08 · 2023: $57.43 · 2024: $67.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $125.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $290.63 | 2019-2020 | |
| Abbvie INC. | $209.57 | 2019-2022 | |
| Tesaro, INC. | $187.44 | 2019 | |
| Lupin INC. | $176.39 | 2019-2021 | |
| Lilly USA, LLC | $111.05 | 2020 | |
| Exeltis, USA INC. | $105.57 | 2019-2024 | Slynd |
| Glaxosmithkline, LLC. | $95.81 | 2019-2020 | |
| Pfizer INC. | $59.62 | 2019-2023 | |
| Mylan Pharmaceuticals INC. | $55.81 | 2019-2022 | |
| Amgen INC. | $55.54 | 2020 | |
| Shield Therapeutics INC | $48.70 | 2023-2024 | Accrufer |
| Hologic Sales and Service, LLC | $41.13 | 2019 | |
| Eisai INC. | $28.77 | 2021 | |
| Avion Pharmaceuticals | $26.75 | 2020-2021 | |
| Duchesnay USA Incorporated | $19.41 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $18.88 | 2019 | |
| Mayne Pharma Commercial LLC | $18.53 | 2022 | |
| Agile Therapeutics, INC. | $17.60 | 2021 | |
| Janssen Pharmaceuticals, INC | $17.23 | 2020 | |
| Daiichi Sankyo INC. | $16.24 | 2020 | |
| Becton, Dickinson and Company | $16.16 | 2019 | |
| Coopersurgical, INC. | $16.11 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $15.82 | 2019 | |
| Clovis Oncology, INC. | $15.51 | 2020 | |
| Octapharma USA, INC. | $13.51 | 2020 | |
| Boston Scientific Corporation | $12.73 | 2019 | |
| Therapeuticsmd, INC. | $11.48 | 2020 | |
| Evofem Biosciences, INC. | $11.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Haskins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.